Several studies have reported an association of Alzheimer's disease (AD) with polymorphic markers in SORL1. Data from a recently published genome-wide association study in AD have been made publicly available. We tested the association of AD with SORL1 in this dataset (Translational Genomics Research Institute; TGEN), which included 31 SORL1 single nucleotide polymorphisms (SNPs), eight of which overlapped the original study. Six SNPs, near the 3 0 region of SORL1 containing SNPs which were strongly associated with AD in previous studies, showed signi¢cant association in the TGEN dataset.These results provide an independent replication of the association between AD and SORL1. NeuroReport18:1761^1764
Introduction
Rogaeva et al. [1] reported an association between Alzheimer's disease (AD) and several single nucleotide polymorphisms (SNPs) in the gene encoding the sortilin-related receptor, low-density lipoprotein receptor class A repeatcontaining protein SORL1 (11q23-q24) in four different ethnic groups (Caucasians, African Americans, Israeli-Arabs and Hispanics) analyzed separately. Although the precise identity of the genetic effectors in SORL1 remains to be determined, this initial study pointed to two clusters of SNPs in distinct regions of the gene, implying the existence of multiple allelic variants associated with AD in different populations. Two positive replications have been reported [2, 3] . Recently, results of a genome-wide association study in AD were published [4] with a focus on a novel association of SNPs in the GAB2 gene with AD. This report however did not mention any results for SORL1. We were therefore interested to test whether the association of AD with SORL1 is replicated in this dataset (Translational Genomics Research Institute; TGEN), which is publicly available.
Methods

Subjects
The TGEN dataset [4] was obtained from the website http://www.tgen.org/neurogenomics/data. Although both the original study by Rogaeva et al. [1] and the study by Reiman et al. [4] describing the TGEN dataset included individuals ascertained at the Mayo Clinic in Rochester, Minnesota, the Mayo individuals in the TGEN data set and the Mayo individuals included in Rogaeva et al. study are independent. Consequently, we analyzed SORL1 data for 1408 individuals in the TGEN database which included 1044 autopsied individuals (641 cases, 403 controls) and 364 clinically examined individuals from the Mayo Clinic (218 cases and 146 controls).
Statistical analyses SNP marker data were assessed for deviations from Hardy-Weinberg equilibrium using Haploview [5] software (http://www.broad.mit.edu/mpg/haploview/index.php). Single point allelic and genotypic tests were performed using PLINK (http://pngu.mgh.harvard.edu/Bpurcell/plink/) [6] . Marker genotype distributions in cases and controls were compared in several ways: (i) a genotypic test with two degrees of freedom, models assuming (ii) dominant and (iii) recessive inheritance, and (iv) the Cochran-Armitage trend test.
Linkage disequilibrium
The linkage disequilibrium (LD) structure among the SORL1 SNPs was examined using Haploview [5] . Haplotype blocks were defined using the confidence intervals algorithm. The default settings were used in these analyses, which create 95% confidence bounds on D 0 to delineate SNP pairs in strong LD.
Results
The TGEN database had 31 SORL1 SNPs, and eight of those overlapped the 29 SNPs in the study by Rogaeva et al. [1] . These 31 SNPs are referred to by their sequential order on the physical map in TGEN database, such as T.1, T.2, T.n, T.31. Therefore, a total of 52 unique SNPs were analyzed in these two studies (Table 1 ). All SNPs are in Hardy-Weinberg equilibrium in control samples. The LD structures of SNPs in the 5 0 and 3 0 regions are similar in the north European family data [1] and TGEN data [2] (Fig. 1) .
Six SNPs (T.17, T.19, T.20, T.21, T.26, T.27) showed nominally significant association (0.01r Po0.05) with AD under at least one model ( Table 2 (Table 2 ). Haplotype analysis strengthened the association signal in the region including the two SNPs between SNPs 22 and 23 (global P¼0.005, data not shown).
Discussion
The results from analysis of the TGEN data provide an independent replication of the association between AD and SORL1. We recognize that the magnitude of the significance of these results would not survive correction for multiple testing in a hypothesis-generating study (e.g. genome-wide association study); however, a P value of less than 0.05 is sufficient to confirm a previously reported association between variants within a specific gene and disease. Furthermore, although the particular SNP associations in this study are novel, a Bonferroni or similar correction is not appropriate or justified because all of the associated SNPs are within the region of and in LD with SNPs implicated in previous investigations [1] [2] [3] , and therefore these are not truly independent tests.
Conclusion
Although the precise identity of genetic effectors in SORL1 remains unknown, the TGEN data support the hypothesis that at least one disease risk enhancing allele is located near the 3 0 end of SORL1. 
